Unbranded vials, oral-liquid bottle, blister packs, neutral cartons, labels and a quality dossier arranged for portfolio review
Products

A strategic B2B portfolio, not a public pharmacy catalogue.

Product categories describe NovaPharm's focus and partnership pipeline. They do not indicate marketing-authorisation ownership, current stock, pricing or availability.

Hand holding unbranded medicine blister packs against a clean blue background
Representative packaging; no licence ownership, stock or availability is implied
Portfolio focus

Category focus is not a claim of availability.

Oncology, specialty and hard-to-source categories remain strategic areas of assessment. Every product requires its own rights, regulatory, quality, source and commercial evidence before release.

Category photography is representative and does not depict NovaPharm-owned premises, current stock or an authorised NovaPharm product.

Gloved laboratory professional using a pipette to handle a vial in a controlled scientific setting
Representative licensed stock image; not a NovaPharm-owned facility or product.
Strategic focus

Oncology medicines

Oral and liquid oncology opportunities evaluated with specialist quality, demand, storage and regulatory requirements.

Explore the continuity model
Gloved laboratory professional using a multichannel pipette during controlled sample analysis
Representative licensed stock image; not a NovaPharm-owned facility or product.
Opportunity assessment

Specialty medicines

Hard-to-source and clinically important categories considered through qualified B2B and regulatory pathways.

Submit a relevant opportunity
Gloved laboratory professional holding an amber glass bottle during liquid analysis
Representative licensed stock image; not a NovaPharm-owned facility or product.
Partner sought

Oral liquid formulations

Technically differentiated liquid formulations requiring robust development, manufacturing and stability evidence.

Submit a relevant opportunity
Hand holding unbranded medicine blister packs against a clean blue background
Representative licensed stock image; not a NovaPharm-owned facility or product.
Regulatory preparation

Selected licensed generics

Established therapeutic categories assessed for compliant sourcing, documentation and commercial viability.

Submit a relevant opportunity
Laboratory scientist examining samples and recording quality-control observations
Representative licensed stock image; not a NovaPharm-owned facility or product.
Strategic focus

Cardiovascular medicines

Selected opportunities within a diversified future portfolio, not a statement of current availability.

Submit a relevant opportunity
Protected workers monitoring medicine packaging on a controlled production line
Representative licensed stock image; not a NovaPharm-owned facility or product.
Subject to approval

Respiratory medicines

Potential licensed products assessed against source, device, packaging and applicable PLPI complexity.

Submit a relevant opportunity
Scientist wearing gloves and safety glasses holding laboratory flasks for analysis
Representative licensed stock image; not a NovaPharm-owned facility or product.
Opportunity assessment

Metabolic medicines

Selected categories considered for manufacturer or authorised-distributor partnerships.

Submit a relevant opportunity
Sealed cartons arranged inside a delivery vehicle for controlled logistics handling
Representative licensed stock image; not a NovaPharm-owned facility or product.
Commercial enquiry

Hospital & hard-to-source products

Qualified B2B enquiries reviewed without implying stock, authorisation or NHS supply.

Submit a relevant opportunity
Food supplement portfolio review

Nutraxin UK catalogue reference.

Review 19 owner-supplied catalogue records with pack imagery and source-transcribed composition information. The catalogue is presented for qualified B2B evaluation and does not state current availability, price, stock, approved claims or medicinal status.

Review the catalogue
Nutraxin Vitamin D3 1000 IU box and 120-tablet bottle
Product opportunity

Bring an evidence-backed B2B opportunity.

Dossier owners, manufacturers and authorised wholesalers can submit an initial enquiry. Do not include patient information, confidential dossiers or adverse-event reports in this form.

  • Dossier-owner enquiry
  • Manufacturer partnership
  • Wholesaler sourcing opportunity
  • UK distribution discussion

Do not include patient-identifiable information, adverse-event reports or urgent medical information. Report suspected medicine side effects through the MHRA Yellow Card service. For emergencies call 999; for urgent NHS advice use 111.

Your information is transmitted to the secure NovaPharm API when the production Node service is active.
Start a qualified conversation

Build the next pharmaceutical partnership with NovaPharm.

Discuss a partnershipOpen an account